<i>TERT</i> Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma.

Cancers (Basel) · 2020 · PMC7463448 · PMID 32784823

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In our cohort, the frequency of TERT promoter alterations tended to be higher in BRAF V600 samples, with 39 mutations in 53 samples (73.6%), than in BRAF WT samples, with 22 mutations in 36 samples (61.1%), although this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.